The Veto War and the Miracle Drug: New Hampshire's Governor Race, Claim by Claim

← Election Series · All governors races

Kelly Ayotte won in 2024 by nearly ten points and now runs against a legislature of her own party that handed her seven veto overrides in a single August day — the most a New Hampshire governor has taken in at least a century. Her challenger, Joyce Craig's successor on the Democratic line, is Cinde Warmington, a health-care lawyer and former Executive Councilor whose file carries the heaviest personal-conduct item in this tranche: a fact-checked, archival-record-proven chapter lobbying and testifying for Purdue Pharma while OxyContin flooded New England — printed below in full, with her documented mitigation carried alongside it, as our standard requires. We endorse the incumbent.

How New Hampshire got here

Governor Kelly Ayotte (R) — U.S. Senator 2011–2017, state attorney general before that, elected governor in 2024 with 53.6% against Joyce Craig's 44.3% — seeks a two-year second term. (Audit note in our file: Ayotte is listed as a candidate in both major 2026 New Hampshire trackers we consulted; her absence from one commercial guide's New Hampshire list appears to be that guide's omission, since no withdrawal or replacement reporting exists in the pass, and we note it rather than bury it.) Cinde Warmington (D) served on the Executive Council 2020–2024 and chairs her campaign on a health-care and affordability program; Joyce Craig, the 2024 nominee, is an announced 2028 candidate, not this cycle's. Jonah Wheeler, once listed as an exploratory Democratic figure, is running for State Senate instead — he is not in this race. The third ticket is Libertarian: Stephen Villee, on the certified ballot; neither party primaries were contested on September 8, 2026. Ratings: Cook "Likely R" (Oct 23), Inside Elections "Solid R" (Oct 15), Sabato "Likely R" (Oct 22) — an undated Sabato board snapshot elsewhere shows "Leans R," which we flag as a compilation conflict rather than resolve. The October polling average (RealClearPolitics) stands at Ayotte 51.1, Warmington 40.6. Money, chronologically and never merged: late 2025, Ayotte reported $2.1 million raised with $1.4 million on hand (Granite State Reports); by June 2026, Ayotte showed about $3.7 million raised against Warmington's roughly $635,000 (NHPR); through September 11, Ayotte stood at $6.1 million-plus raised with $2.6 million on hand, Warmington at roughly $937,000 with over $400,000 on hand (Inside Elections' compilation); an October New Hampshire Journal total put Ayotte past $8.5 million and Warmington around $1.37 million. The resource gap is wide and consistent across every snapshot.

The outgoing Legislature: Senate 16 Republicans, 8 Democrats — exactly two-thirds, a veto-proof majority when it holds — and a House near 220 Republicans from the 2024 vote reaching the mid-180s Democrats in later snapshots, with special-election drift in between; all 424 seats are on this ballot. That exact-two-thirds Senate is the arithmetic behind the veto war below.

Kelly Ayotte (R) — the check, exercised in both directions

The governing record. Ayotte signed the core of her party's program: the FY26–27 budget, universal Education Freedom Accounts, an anti-sanctuary package (HB 511 and SB 62, which she signed in 2025), expanded bail reform, and a housing slate (YIMBY measures, religious-land-use and manufactured-housing protections, eased accessory-dwelling rules). State housing permits hit their highest level since 2006 in 2025 — while the median single-family price reached about $580,000, among the nation's highest; we print the supply record and the price record together and credit or blame neither causally. On the EFA expansion, the proven data cut against the program's framing: per Department of Education figures reported by Axios, 96.7% of participating students were already in private school or homeschooling when the expansion passed. Ayotte's own framing is on the record — she said the program would have passed "regardless" of whether she held the office — and we print the data and her words side by side.

The vetoes, counted honestly. Two compilations of her 2025 session disagree: the conservative New Hampshire Journal reported 11 of 11 vetoes sustained and zero overrides at session's end; New Hampshire Bulletin reported 12 vetoes with one override — SB 262, the EFA income-cap bill she vetoed precisely because it capped a program she wanted uncapped, overridden with her own party supplying the votes. We print both counts and resolve neither. The 2026 count disagrees the same way — 32 vetoes (NH Bulletin's session coverage) against 33 (WMUR's Veto Day framing) — but both agree on the event that defines the session: on Veto Day, August 19, 2026, the Legislature overrode her seven times, reported as the most overrides handed any New Hampshire governor in at least a century. Under this series' doctrine a veto count is no flaw by itself — and Ayotte's veto targets tell the real story: she vetoed her own party's social wing (biological-sex bills in 2025 and 2026, school library book-removal bills twice, vaccine-exemption removal, partisan school-board elections) while signing its fiscal, choice, housing, and enforcement program, and she defended an MMR vaccine requirement in unambiguous terms ("Unequivocally yes. MMR saves lives."). Those vetoes were judgment calls inside her own coalition, stated on the record with pragmatic reasons — not a governing method wielded against a hostile legislature, and not the Hobbs case in any respect. We price the seven overrides as documented legislative friction: her party's legislature publicly disciplined its own governor, and she governed on. Her Medicaid premium policy is printed at exact status because its status is the fact voters most often get wrong: the work-reporting requirements and premiums (up to $270 per month on the detailed schedule, from $10 for lower-income enrollees; one report's lead figure said $300 — we print both) were proposed and signed into the budget law but had not taken effect as of October 2026, suspended pending federal approval. Promises in either direction about premiums New Hampshire is not yet charging should be weighed as such.

Cinde Warmington (D) — the Purdue chapter, in full

The proven record. Warmington's biography is documented: a health-law career at Shaheen & Gordon beginning in 1999, New Hampshire Senate counsel in 2019 (part-time, while keeping her firm partnership), Executive Councilor 2020–2024 — where she chaired the Council's Finance Committee and cast the lone Democratic vote, as the only Democrat on the body, against confirming Gordon MacDonald as chief justice in 2019 (her campaign's account, citing Boston Globe and InDepthNH coverage) — and before all of it, in 2001–2002, registered lobbying work for Purdue Pharma, the maker of OxyContin. That last item is the one that matters, and it is proven, not alleged: PolitiFact (Oct 6, 2026) and Snopes (Oct 2026) both rated the core claims TRUE from the archival record — her registration documents (2001 as a registered lobbyist for Purdue; 2002 as an external lobbyist), and a 2001 New Hampshire House hearing transcript in which she testified against HB 1218, a bill to put OxyContin on the state's triplicate prescription program, calling the drug a "miracle drug" with "very few side effects." Personal lobbying for the company at the center of the opioid epidemic, in her own words on a hearing transcript, prices in this series as personal conduct — the heaviest species — and we print it without softening.

Her mitigation, carried in full beside it. Warmington's account, given to the fact-checkers themselves: the lobbying ended in 2001 or 2002 — her first or second year at the firm; she "never would have accepted Purdue Pharma as a client had she known of their fraudulent marketing at the time"; she cites her family's experience with addiction; she did no further pharmaceutical lobbying; and she points to subsequent work on substance-misuse issues. We carry all of it, because our standard prints the defense at the same weight as the record. The Ayotte campaign's extension of the record — that Warmington "spent her career as a lobbyist for the opioid industry" and is "absolutely disqualified" — goes beyond what the archival record proves about two years at a career's start, and we print that framing as a campaign claim, not as a finding; the record is bad enough at its true size and needs no enlarging. (A related counter-claim from critics — that Ayotte received Sackler-family money through a leadership PAC — appears in the PolitiFact item as a critics' point and was not independently verified in our pass; we print it flagged as such, and it figures in no part of our call.) Her service ceiling is Executive Council — five-member budget oversight, not chief-executive command — so as a would-be governor she is unproven in our pricing: a watch posture, not a demerit. Her program (federal-style child-care cost caps, housing, property-tax relief funded by closing tax gaps) carries no costed arithmetic in the sourced record — a gap we print as a gap. But the call in this race does not turn on her ceiling or her program. It turns on a proven, fact-checked personal-conduct record from her own mouth in a legislative hearing room, defending the drug that helped ignite the worst addiction crisis in her state's modern history — mitigated, genuinely, and not erased.

Stephen Villee (L), briefly. The Libertarian ticket is on the certified ballot; our pass carries no sourced program or service record for him, and he does not figure in the call.

OUR CALL

LiberalMind endorses Kelly Ayotte.

Ayotte's file is a proven governing record aligned with this mission: the budget, universal school choice, the anti-sanctuary laws, bail reform, and a housing-supply program signed into law — with her vetoes spent inside her own coalition's excesses and the state's first same-party veto war in a century absorbed without her program moving an inch. The frictions are real and printed: an EFA expansion whose own department data show 96.7% of participants were already outside public schools, a Medicaid premium schedule signed but not yet in effect, and a legislature of her own party that overrode her seven times in a day. None of it is disqualifying, and none of it is hidden. Against her stands a challenger whose candidacy we could otherwise weigh as an unproven executive with a mainstream program — except for the chapter of her record that two independent fact-checks verified from the archives: she took Purdue Pharma's money to lobby for OxyContin and told a legislative committee it was a miracle drug. Her mitigation is honest and printed in full above; it explains the two years, and it does not undo them. Proven conduct of that order, against a proven governor governing in our direction, settles the call. We endorse the incumbent.

Read the full Election 2026 coverage — every Senate, House, and governor's race, claim by claim — on our website.

Vote early. Research your candidates. Choose the best moderates, whatever their party — no extremism from either side. And encourage your friends and family to do the same.

### Sources

New Hampshire Secretary of State (certified 2026 candidate listings) · Cook Political Report (Oct 23, 2026) · Inside Elections (Oct 15, 2026) · Sabato's Crystal Ball (Oct 22, 2026) · RealClearPolitics polling average (Oct 2026) · New Hampshire Bulletin (2025 and 2026 veto tallies; Veto Day, Aug 19, 2026) · New Hampshire Journal (2025 veto tally — conflicting compilation) · WMUR (Veto Day framing) · PolitiFact (Warmington–Purdue rating, Oct 6, 2026) · Snopes (Warmington–Purdue rating, Oct 2026) · Axios New Hampshire (EFA participation data) · NHPR · Granite State Reports · Campaign-finance compilations as cited (Granite State Reports; NHPR; Inside Elections) · Candidate platforms and statements as quoted, including the Ayotte campaign and the Warmington campaign.

AI-assisted article — but the sources are human, and the facts are very real.

← Back to the Election Series